- Release Date: 15/02/24 08:29
- Summary: Phase 1 onCARlytics Trial Doses First Intravenous Patient
- Price Sensitive: Yes
- Download Document 192.99KB
- Forums
- ASX - By Stock
- IMU
- Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
Ann: Phase 1 onCARlytics Trial Doses First Intravenous Patient
-
- There are more pages in this discussion • 104 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMU (ASX) to my watchlist
|
|||||
Last
5.3¢ |
Change
0.001(0.96%) |
Mkt cap ! $382.1M |
Open | High | Low | Value | Volume |
5.2¢ | 5.4¢ | 5.2¢ | $179.9K | 3.405M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
31 | 2197015 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.3¢ | 286263 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
31 | 2197015 | 0.052 |
40 | 3985487 | 0.051 |
70 | 5873895 | 0.050 |
18 | 2391726 | 0.049 |
21 | 798435 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.053 | 286263 | 10 |
0.054 | 2196873 | 18 |
0.055 | 3657119 | 14 |
0.056 | 2701070 | 13 |
0.057 | 446030 | 6 |
Last trade - 12.26pm 26/08/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online